CN102869357A - 舒欣啶及其盐的缓慢滴注 - Google Patents

舒欣啶及其盐的缓慢滴注 Download PDF

Info

Publication number
CN102869357A
CN102869357A CN2010800519066A CN201080051906A CN102869357A CN 102869357 A CN102869357 A CN 102869357A CN 2010800519066 A CN2010800519066 A CN 2010800519066A CN 201080051906 A CN201080051906 A CN 201080051906A CN 102869357 A CN102869357 A CN 102869357A
Authority
CN
China
Prior art keywords
minutes
active agent
administration
pharmaceutically acceptable
infusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800519066A
Other languages
English (en)
Chinese (zh)
Inventor
加里·T·艾略特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica
Huya Bioscience International LLC
Original Assignee
Huya Bioscience International LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huya Bioscience International LLC filed Critical Huya Bioscience International LLC
Publication of CN102869357A publication Critical patent/CN102869357A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2010800519066A 2009-11-17 2010-11-16 舒欣啶及其盐的缓慢滴注 Pending CN102869357A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26192709P 2009-11-17 2009-11-17
US61/261,927 2009-11-17
PCT/US2010/056849 WO2011062903A2 (en) 2009-11-17 2010-11-16 Slow infusion of sulcardine and its salts

Publications (1)

Publication Number Publication Date
CN102869357A true CN102869357A (zh) 2013-01-09

Family

ID=44060289

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800519066A Pending CN102869357A (zh) 2009-11-17 2010-11-16 舒欣啶及其盐的缓慢滴注

Country Status (7)

Country Link
US (1) US8637566B2 (cg-RX-API-DMAC10.html)
EP (1) EP2501380B1 (cg-RX-API-DMAC10.html)
JP (2) JP6116907B2 (cg-RX-API-DMAC10.html)
CN (1) CN102869357A (cg-RX-API-DMAC10.html)
ES (1) ES2569123T3 (cg-RX-API-DMAC10.html)
PL (1) PL2501380T3 (cg-RX-API-DMAC10.html)
WO (1) WO2011062903A2 (cg-RX-API-DMAC10.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112516136A (zh) * 2019-09-17 2021-03-19 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
CN112638903A (zh) * 2019-01-29 2021-04-09 沪亚生物国际有限责任公司 舒欣啶盐
CN114984004A (zh) * 2022-05-25 2022-09-02 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用
CN116723836A (zh) * 2020-06-12 2023-09-08 沪亚生物国际有限公司 用于治疗急性心房颤动的舒欣啶施用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299813A (zh) * 1999-12-10 2001-06-20 中国科学院上海药物研究所 N－取代苄基或苯基芳香磺酰胺化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299813A (zh) * 1999-12-10 2001-06-20 中国科学院上海药物研究所 N－取代苄基或苯基芳香磺酰胺化合物及其用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王唯等: "舒欣啶对麻醉兔心脏电生理的作用", 《中国药理学会通讯》, vol. 19, no. 4, 30 April 2002 (2002-04-30), pages 63 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112638903A (zh) * 2019-01-29 2021-04-09 沪亚生物国际有限责任公司 舒欣啶盐
CN112638903B (zh) * 2019-01-29 2022-08-26 沪亚生物国际有限公司 舒欣啶盐
CN115385871A (zh) * 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐
CN112516136A (zh) * 2019-09-17 2021-03-19 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
CN116723836A (zh) * 2020-06-12 2023-09-08 沪亚生物国际有限公司 用于治疗急性心房颤动的舒欣啶施用
CN114984004A (zh) * 2022-05-25 2022-09-02 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Also Published As

Publication number Publication date
PL2501380T3 (pl) 2016-08-31
JP6173391B2 (ja) 2017-08-02
JP2016014034A (ja) 2016-01-28
US8637566B2 (en) 2014-01-28
WO2011062903A2 (en) 2011-05-26
JP6116907B2 (ja) 2017-04-19
EP2501380B1 (en) 2016-01-27
JP2013511472A (ja) 2013-04-04
WO2011062903A9 (en) 2011-09-09
ES2569123T3 (es) 2016-05-06
EP2501380A2 (en) 2012-09-26
EP2501380A4 (en) 2013-05-22
US20120245214A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
US8188140B2 (en) Uses of ion channel modulating compounds
EP2501381B1 (en) Treatment of atrial fibrillation
CZ290101B6 (cs) Farmaceutický prostředek sestávající z kombinace metforminu a fibrátu a jeho použití k přípravě léčiv určených ke snižování hyperglykémie
AU2019397511B2 (en) Sulcardine administration for treatment of acute atrial fibrillation
JP2013511473A5 (cg-RX-API-DMAC10.html)
JP2013511472A5 (cg-RX-API-DMAC10.html)
US20090041841A1 (en) Controlled release tablet formulations for the prevention of arrhythmias
CN116723836A (zh) 用于治疗急性心房颤动的舒欣啶施用
RU2358732C2 (ru) Жидкие фармацевтические композиции, содержащие производные 3,7-диазабицикло(3,3,1)нонана, для лечения антиаритмических реакций
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
HK1176858B (en) Slow infusion of sulcardine and its salts
HK1176859A (en) Treatment of atrial fibrillation
HK1176859B (en) Treatment of atrial fibrillation
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
HK40061591A (en) Sulcardine administration for treatment of acute atrial fibrillation
Gombotz et al. First clinical experience with the rapid-, short-acting amiodarone derivative E 047/1 after cardiac surgery

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Elliot Gary T.

Inventor after: Bai Donglu

Inventor after: Wang Yiping

Inventor before: Elliot Gary T.

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20150910

Address after: American California

Applicant after: HUYA Bioscience International, LLC

Applicant after: Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Address before: American California

Applicant before: HUYA Bioscience International, LLC

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130109